VP/Director of Payer Growth at Roivant Sciences

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, Healthcare TechnologyIndustries

Requirements

Exceptional academic background
Proven track record of successfully signing new payer and strategic partnerships within a fast-paced healthcare technology and/or services company
Deep familiarity with the health insurance ecosystem, including an in-depth understanding of strategic priorities, operational challenges, governance structures, and contracting mechanisms
Detailed experience in a specific geography, market or lines of business is welcomed though not essential
Demonstrated ability to operate independently and entrepreneurially in a fast-paced environment
Excellent strategic, communication, and execution skills
Strong business development, negotiation, and relationship management skills are highly valued

Responsibilities

Lead sales and partnership efforts with national and regional payers across lines of business to drive adoption and scale for Roivant Health’s portfolio companies
Drive go-to-market strategy and implementation, including both hands-on lead generation and high-level sales motions to support the entire sales pipeline through to contracting
Support the development and execution of value-based care strategies and contracts in collaboration with Roivant Health and Vant leadership
Collaborate closely with the leadership teams of individual Roivant Health Vants to understand their specific needs and tailor business development approaches for optimal market fit and growth
Provide market insights from the payer landscape back to Roivant Health's incubation teams to inform product development and go-to-market strategies

Skills

Sales Leadership

Payer Negotiations

Partnership Development

Healthcare Payers

Market Penetration

Business Development

Entrepreneurial Leadership

Growth Strategy

Roivant Sciences

Develops biopharmaceuticals and RNA therapeutics

About Roivant Sciences

Roivant Sciences develops and delivers medicines and technologies aimed at improving patient health, focusing on drug candidates for genetic disorders and RNA therapeutics. The company operates in the biopharmaceutical market, which involves creating drugs from biological sources. Roivant's unique business model combines in-house development with strategic partnerships, allowing it to build a strong pipeline of drug candidates and utilize advanced technologies to meet medical needs. A key subsidiary, Genevant, specializes in RNA therapeutics, employing proprietary delivery platforms for mRNA, RNAi, and gene editing to treat specific diseases. Roivant generates revenue through drug development, licensing agreements, and partnerships, with the goal of bringing innovative treatments to market efficiently.

New York City, New YorkHeadquarters

2014Year Founded

$1,750.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Risks

Integration challenges from Dermavant acquisition may disrupt operations and delay development.

Regulatory hurdles in Pulmovant collaboration with Bayer could impede progress.

Failure of lupus drug brepocitinib may lead to financial losses and investor concerns.

Differentiation

Roivant Sciences focuses on late-stage drug candidates, reducing development time and cost.

The company builds Vants, nimble biotech firms, to enhance drug development efficiency.

Roivant leverages RNA therapeutics, including mRNA and RNAi, for innovative treatments.

Upsides

Roivant's acquisition of Dermavant expands its dermatology portfolio and therapeutic areas.

Strategic partnerships with Bayer and Roche accelerate drug development and market entry.

Increased investment from financial institutions highlights confidence in Roivant's growth potential.

Land your dream remote job 3x faster with AI

Try Jobo Free